Study outcomes
TIA, extracranial haemorrhage, venous thromboembolism, ischaemic stroke
MYOCARDIAL INFARCTION, ISCHAEMIC STROKE, INTRACRANIAL HAEMORRHAGE, SECONDARY, TRANSIENT ISCHAEMIC ATTACKS, EVENTS, TIA
The primary outcome was The secondary outcomes were:percentage of patients with overall timing adherence (proportion of doses taken within the grace interval, absolute value),overall taking adherence (proportion of doses taken, absolute value),occurrence of predefined clinical events of interest (recurrent ischaemic stroke, transient ischaemic attacks (TIA), intracranial haemorrhage, major extracranial haemorrhage, myocardial infarction, venous thromboembolism, death),patient satisfaction with the reminder (questionnaire, 5-point Likert-Scale).